In general, our study indicated that the frequency of BRCA1 promoter methylation was statistically significant elevated in breast cancers compared with non-cancer controls (OR = 3.15, 95%CI 1.97–5.03, P < 0.001, Fig. 2). The gene discussed is BRCA1; the disease is cancer.